Sana Biotechnology (NASDAQ:SANA) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips [Seeking Alpha]
Assessing Sana Biotechnology (SANA) Valuation After Recent Share Price Momentum [Yahoo! Finance]
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
Sana Biotechnology (NASDAQ:SANA) had its price target raised by analysts at Bank of America Corporation from $6.00 to $7.00. They now have a "buy" rating on the stock.